Low dose IL ‐2 suppress osteoclastogenesis in collagen‐induced arthritis via JNK dependent pathway
ConclusionIt is the first time for us to prove that low dose IL ‐2 can inhibit osteoclast formation in collagen‐induced arthritis through the JNK dependent pathway, which will provide the angle and theoretical basis for future immunotherapy of IL‐2.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Han Sun,
Yong Zhao,
Kun Wang,
Li Zhu,
Jian Dong,
Jie Zhao,
Yimin Wang,
Huan Li,
Xiaoliang Sun,
Yunjie Lu Tags: ORIGINAL RESEARCH Source Type: research
More News: Allergy & Immunology | Arthritis | Hormones | Immunotherapy | Pathology | Rheumatology | Statistics